Using established biomarkers for breast cancer which are currently available in clinical practice, we first developed a predictive model including HSP90AA1, which can be used to calculate breast cancer risk for breast disease and risk of distant metastasis in breast cancer. The gene discussed is HSP90AA1; the disease is breast disorder.